SCHERMA, MARIA
 Distribuzione geografica
Continente #
EU - Europa 119.413
NA - Nord America 7.322
AS - Asia 3.265
SA - Sud America 485
Continente sconosciuto - Info sul continente non disponibili 328
AF - Africa 100
OC - Oceania 9
Totale 130.922
Nazione #
IT - Italia 117.636
US - Stati Uniti d'America 7.161
SG - Singapore 1.216
CN - Cina 1.059
SE - Svezia 448
BR - Brasile 387
VN - Vietnam 315
UA - Ucraina 293
DE - Germania 226
FI - Finlandia 206
GB - Regno Unito 194
FR - Francia 138
IN - India 101
HK - Hong Kong 90
CA - Canada 86
KR - Corea 77
BD - Bangladesh 71
NL - Olanda 71
TR - Turchia 65
AR - Argentina 40
ES - Italia 39
IQ - Iraq 39
JP - Giappone 31
MX - Messico 31
PL - Polonia 29
PK - Pakistan 28
AT - Austria 22
SA - Arabia Saudita 22
ZA - Sudafrica 22
MA - Marocco 20
UZ - Uzbekistan 20
EC - Ecuador 19
PH - Filippine 15
BE - Belgio 14
RU - Federazione Russa 14
IE - Irlanda 13
JO - Giordania 13
CZ - Repubblica Ceca 12
IR - Iran 12
JM - Giamaica 12
CO - Colombia 11
NP - Nepal 11
ET - Etiopia 10
EG - Egitto 9
ID - Indonesia 9
AE - Emirati Arabi Uniti 8
LT - Lituania 8
VE - Venezuela 8
AU - Australia 7
IL - Israele 7
KE - Kenya 7
AZ - Azerbaigian 6
CL - Cile 6
MY - Malesia 6
CH - Svizzera 5
DO - Repubblica Dominicana 5
GR - Grecia 5
HR - Croazia 5
OM - Oman 5
PA - Panama 5
TH - Thailandia 5
TN - Tunisia 5
BB - Barbados 4
CI - Costa d'Avorio 4
CR - Costa Rica 4
DZ - Algeria 4
GE - Georgia 4
HU - Ungheria 4
KZ - Kazakistan 4
LB - Libano 4
NG - Nigeria 4
RS - Serbia 4
SN - Senegal 4
TT - Trinidad e Tobago 4
UY - Uruguay 4
AM - Armenia 3
BA - Bosnia-Erzegovina 3
BG - Bulgaria 3
KW - Kuwait 3
LV - Lettonia 3
NO - Norvegia 3
PT - Portogallo 3
PY - Paraguay 3
RO - Romania 3
EU - Europa 2
GD - Grenada 2
HN - Honduras 2
KH - Cambogia 2
LK - Sri Lanka 2
LU - Lussemburgo 2
MD - Moldavia 2
MM - Myanmar 2
MN - Mongolia 2
NA - Namibia 2
NI - Nicaragua 2
NZ - Nuova Zelanda 2
PE - Perù 2
PR - Porto Rico 2
QA - Qatar 2
SC - Seychelles 2
Totale 130.571
Città #
Cagliari 113.877
Uta 3.221
Ashburn 702
Singapore 604
Fairfield 589
San Jose 423
Woodbridge 416
Dallas 411
Chandler 360
Houston 308
Ann Arbor 279
Boardman 261
Nyköping 255
Seattle 248
Wilmington 208
Beijing 198
Council Bluffs 189
Cambridge 186
Los Angeles 161
Jacksonville 155
Dearborn 127
Santa Clara 125
New York 124
Helsinki 119
Shanghai 113
Hefei 87
Ho Chi Minh City 83
Hong Kong 81
Boston 75
The Dalles 74
Lauterbourg 71
Seoul 68
Hanoi 67
Munich 62
Nanjing 61
Dong Ket 45
Milan 44
Buffalo 40
Frankfurt am Main 39
Orem 38
Rome 37
Chennai 35
San Diego 35
Shenyang 34
Denver 33
São Paulo 33
Washington 32
Columbus 31
Redwood City 29
Turku 29
Atlanta 28
Chicago 27
Amsterdam 26
London 26
Tokyo 25
Toronto 25
Kocaeli 24
Madrid 23
Phoenix 23
Brooklyn 21
Guangzhou 21
Montreal 21
Redondo Beach 21
Warsaw 21
Manchester 19
Mountain View 19
San Francisco 18
Tashkent 18
Tianjin 17
Nuremberg 16
Poplar 16
Baghdad 15
Sassari 15
Verona 15
Wuhan 15
Baltimore 14
Tucson 14
Brussels 13
Dublin 13
Düsseldorf 13
Hebei 13
Jiaxing 13
Rio de Janeiro 13
Stockholm 13
Vienna 13
Da Nang 12
Lappeenranta 12
Mexico City 12
Amman 11
Arlington 11
Brasília 11
Casablanca 11
Changsha 11
Johannesburg 11
Addis Ababa 10
City of London 10
Porto Alegre 10
Shenzhen 10
Tertenìa 10
Haverhill 9
Totale 125.730
Nome #
Longitudinal assessment of brain-derived neurotrophic factor in Sardinian psychotic patients (LABSP): a protocol for a prospective observational study 6.679
Δ9-Tetrahydrocannabinol prevents methamphetamine-induced neurotoxicity 3.918
Adolescent Δ 9-Tetrahydrocannabinol exposure alters WIN55,212-2 self-administration in adult rats 3.388
Interactions between the endocannabinoid and nicotinic cholinergic systems: preclinical evidence and therapeutic perspectives 3.364
Cannabinoid CB1/CB2 receptor agonists attenuate hyperactivity and body weight loss in a rat model of activity-based anorexia 3.349
Emotional profile of female rats showing binge eating behavior 3.264
Limited access to a high fat diet alters endocannabinoid tone in female rats 3.104
Enhanced self-administration of the CB1 receptor agonist WIN55,212-2 in olfactory bulbectomized rats: evaluation of possible serotonergic and dopaminergic underlying mechanisms 2.980
The Role of the Endocannabinoid System in Eating Disorders: Neurochemical and Behavioural Preclinical Evidence. 2.968
Cannabinoid Modulation of Eukaryotic Initiation Factors (eIF2α and eIF2B1) and Behavioral Cross-Sensitization to Cocaine in Adolescent Rats 2.910
Behavioural and neurochemical assessment of salvinorin A abuse potential in the rat 2.886
Adolescent THC exposure and vulnerability to drug abuse: Sex differences 2.856
Inhibition of N-acylethanolamine acid amidase reduces nicotine-induced dopamine activation and reward 2.830
New perspectives on the use of cannabis in the treatment of psychiatric disorders 2.724
Impaired brain endocannabinoid tone in the activity-based model of anorexia nervosa 2.605
The longitudinal trajectory of serum brain-derived neurotrophic factor (BDNF) levels in psychotic patients: a prospective observational study 2.603
BDNF serum levels as a biomarker of depressive symptoms in psychotic disorders 2.518
Pharmacological modulation of the endocannabinoid signalling alters binge-type eating behaviour in female rats. 2.484
Gene knockout animal models of depression, anxiety and obsessive compulsive disorders 2.403
The endocannabinoid system: Anorexia nervosa and binge eating disorder 2.398
The impact of depot and long acting injectable antipsychotics on serum levels of brain-derived neurotrophic factor in schizophrenic and schizoaffective patients: results of a 24-month longitudinal prospective study 2.364
Brain activity of anandamide: a rewarding bliss? 2.283
CB2 antagonist AM630, monoacylglycerol lipase inhibitor JZL184 and cannabidiol did not affect hedonic properties of food in rats with binge eating behavior 2.237
Blockade of nicotine reward and reinstatement by activation of alpha-type peroxisome proliferator-activated receptors 2.236
Animal Models of Eating Disorders 2.171
Δ9-Tetrahydrocannabinol During Adolescence Attenuates Disruption of Dopamine Function Induced in Rats by Maternal Immune Activation 2.026
Alpha-Synuclein transgenic mice, h-α-SynL62, display α-Syn aggregation and a dopaminergic phenotype reminiscent of Parkinson's disease 1.962
Cannabinoid exposure in rat adolescence reprograms the initial behavioral, molecular, and epigenetic response to cocaine 1.890
Adolescent cannabinoid exposure induces irritability-like behavior and cocaine cross-sensitization without affecting the escalation of cocaine self-administration in adulthood 1.873
Reducing cannabinoid abuse and preventing relapse by enhancing endogenous brain levels of kynurenic acid 1.805
Evaluation of behavioral phenotypes in rats showing binge eating behavior 1.771
Altered brain levels of arachidonic acid-derived inflammatory eicosanoids in a rodent model of anorexia nervosa 1.687
AM404 attenuates reinstatement of nicotine seeking induced by nicotine-associated cues and nicotine priming but does not affect nicotine- and food-taking 1.655
Epigenetic regulation of the cannabinoid receptor CB1 in an activity-based rat model of anorexia nervosa 1.514
Conditioned place preference (CPP) in rats: From conditioning to reinstatement test 1.498
The anandamide transport inhibitor AM404 reduces the rewarding effects of nicotine and nicotine-induced dopamine elevations in the nucleus accumbens shell in rats. 1.459
Rimonabant reduces fat intake in a behavioural model of binge-type eating 1.444
Baclofen prevents drug-induced reinstatement of extinguished nicotine-seeking behaviour and nicotine place preference in rodents 1.374
Self-administration of the anandamide transport inhibitor AM404 by squirrel monkeys 1.338
Cannabinoids and their therapeutic applications in mental disorders 1.282
Exploring the association between brain-derived neurotrophic factor levels and longitudinal psychopathological and cognitive changes in Sardinian psychotic patients 1.269
The endogenous cannabinoid anandamide has effects on motivation and anxiety that are revealed by fatty acid amide hydrolase (FAAH) inhibition 1.187
Dopamine and serotonin release in dorsal striatum and nucleus accumbens is differentially modulated by morphine in DBA/2J and C57BL/6J mice 1.167
Modeling Parkinson’s disease neuropathology and symptoms by intranigral inoculation of preformed human α-synuclein oligomers 1.152
Inhibition of anandamide hydrolysis by cyclohexyl carbamic acid 3'-carbamoyl-3-yl ester (URB597) reverses abuse-related behavioral and neurochemical effects of nicotine in rats 1.138
The endocannabinoid system: a new molecular target for the treatment of tobacco addiction 1.082
K18- and CAG-hACE2 Transgenic Mouse Models and SARS-CoV-2: Implications for Neurodegeneration Research 1.068
Cannabinoid-opioid interaction in relapse to drug-seeking 1.066
Repeated exposure to JWH-018 induces adaptive changes in the mesolimbic and mesocortical dopamine pathways, glial cells alteration and behavioural correlates 1.040
The Intranigral Infusion of Human-Alpha Synuclein Oligomers Induces a Cognitive Impairment in Rats Associated with Changes in Neuronal Firing and Neuroinflammation in the Anterior Cingulate Cortex 1.035
Endocannabinoid system and opioid addiction: behavioural aspects 1.023
Fatty acid amide hydrolase (FAAH) inhibition enhances memory acquisition through activation of PPAR-alpha nuclear receptors. 973
Baclofen antagonizes nicotine-, cocaine-, and morphine-induced dopamine release in the nucleus accumbens of rat 967
Inhibition of anandamide hydrolysis by cyclohexyl carbamic acid 3′-carbamoyl-3-yl ester (URB597) reverses abuse-related behavioral and neurochemical effects of nicotine in rats (Journal of Pharmacology and Experimental Therapeutics (2008) 327, (482-490)) (Erratum) 949
Changed accumbal responsiveness to alcohol in rats pre-treated with nicotine or the cannabinoid receptor agonist WIN 55,212-2 879
Effect of cannabinoids on reinstatement of morphine conditioned place preference (CPP) in mice 869
Nicotinic α7 receptors as a new target for treatment of cannabis abuse 852
Identifying Neurobiological Markers in Obsessive–Compulsive Disorder: A Study Protocol for a Cross-Sectional Study in Subgroups of Differing Phenotype 824
The CB1 receptor antagonist AM251 blocks drug-induced reinstatement of nicotine conditioned place preference in rats 784
Effect of Baclofen on Nicotine, Cocaine and Morphine-induced dopamine release in the shell portion of the nucleus accumbens of rat 780
Converging Evidence Points to BDNF as Biomarker of Depressive Symptoms in Schizophrenia-Spectrum Disorders 772
Baclofen antagonizes nicotine-, cocaine-, and morphine-induced dopamine release in the nucleus accumbens of rat 762
Nicotinic facilitation of delta-9-tetrahydrocannabinol discrimination involves endogenous anandamide 748
CB1 agonist administration modify 5-HT release in the nucleus accumbens and striatum of freely moving rats 745
null 738
null 711
Involvement of the 5-HT1a serotonergic receptors in the anxiety-like effects induced by the CB1 cannabinoid receptor agonist WIN 55,212-2 684
Cannabinoid mechanism in relapse to Heroin after extended abstinence in rats 584
Maternal immune activation impairs endocannabinoid signaling in the mesolimbic system of adolescent male offspring 577
Fluctations of extracellular dopamine levels in the shell portion of the rat nucleus accumbens during cannabinoid self-administration 573
Effect of cannabinoid CB1 receptor agonist WIN 55,212-2 in the elevated plus maze test: role of the serotonergic system 556
An overall view of the most common experimental models for multiple sclerosis 552
Induction of Activity-Regulated Cytoskeleton-Associated Protein and c-Fos Expression in an Animal Model of Anorexia Nervosa 541
Symptomatic remission and recovery in major psychosis: Is there a role for BDNF? A secondary analysis of the LABSP cohort data 483
Anaplastic Lymphoma Kinase Receptor: Possible Involvement in Anorexia Nervosa 452
Modeling Anorexia Nervosa 404
A Secondary Analysis of the Complex Interplay between Psychopathology, Cognitive Functions, Brain Derived Neurotrophic Factor Levels, and Suicide in Psychotic Disorders: Data from a 2-Year Longitudinal Study 385
The Role of Lysophosphatidic Acid in Neuropsychiatric and Neurodegenerative Disorders 355
Cannabinoids and reward: Interactions with the opioid system 335
Activity-based anorexia (ABA) model: Effects on brain neuroinflammation, redox balance and neuroplasticity during the acute phase 295
Cannabinoid self-administration increases dopamine release in the nucleus accumbens 295
Do Long-Acting Injectable Antipsychotics Influence Serum Levels of Brain-Derived Neurotrophic Factor in People with Schizophrenia and Schizoaffective Disorder? 264
Food restriction and hyperactivity induce changes in corticolimbic brain dopamine and serotonin levels in female rats 214
Impact of repetitive transcranial magnetic stimulation on clinical and cognitive outcomes, and brain-derived neurotrophic factor levels in treatment-resistant depression 178
Synaptoproteomic Analysis of the Prefrontal Cortex Reveals Spatio-Temporal Changes in SYNGAP1 Following Cannabinoid Exposure in Rat Adolescence 178
Antibody conjugates in neuroblastoma: a step forward in precision medicine 157
The clock is ticking on schizophrenia: a study protocol for a translational study integrating phenotypic, genomic, microbiome and biomolecular data to overcome disability 132
Cannabinoid-nicotine interactions 48
Totale 130.922
Categoria #
all - tutte 168.768
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 168.768


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20226.551 0 507 284 662 847 523 355 327 678 873 880 615
2022/202311.489 792 1.339 1.631 923 891 1.188 695 923 805 803 1.015 484
2023/202411.092 518 379 465 692 1.162 1.916 1.828 726 615 808 937 1.046
2024/202522.262 5.683 5.870 2.906 2.449 1.151 1.358 1.625 156 285 215 249 315
2025/20267.204 749 510 777 635 551 531 979 306 482 899 465 320
2026/2027647 241 406 0 0 0 0 0 0 0 0 0 0
Totale 130.922